Nov 16 (Reuters) - Auscann Group Holdings Ltd (AC8) :
- TO ACQUIRE 100% OF CANNPAL ANIMAL THERAPEUTICS LIMITED FOR APPROXIMATELY $17.5M
- OFFER VALUES EACH CP1 SHARE AT $0.184
- BOARD OF CANNPAL UNANIMOUSLY RECOMMENDS CANNPAL SHAREHOLDERS VOTE IN FAVOUR OF SCHEME
- Forums
- ASX - By Stock
- CP1
- News: CP1 Auscann To Buy CannPal Animal Therapeutics For About $17.5 Mln
News: CP1 Auscann To Buy CannPal Animal Therapeutics For About $17.5 Mln
Featured News
Add CP1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online